Bris­tol My­ers cell ther­a­py man­u­fac­tur­ing site gets thumbs-up from FDA

A new Bris­tol My­ers Squibb cell man­u­fac­tur­ing site that is ex­pect­ed to make the CAR-T ther­a­py Breyanzi has re­ceived FDA ap­proval to start pro­duc­tion. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.